Xenon Pharmaceuticals (XENE) Misses Q4 EPS by 12c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q4 EPS of ($1.31), $0.12 worse than the analyst estimate of ($1.19).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Super League Enterprise (SLE) files for 1.07M share offering by selling stockholders
• MIND Technology (MIND) Misses Q1 EPS by 5c